A Study of Tirzepatide (LY3298176) in Pediatric Participants With Obesity
This study looks at how safe and tolerable a new medicine called tirzepatide (LY3298176) is for kids with obesity, which means having too much body fat. The study will last about 13 weeks, not counting the time needed to check if you're eligible. To join, you must have a Body Mass Index (BMI) at or above the 95th percentile for your age and sex, and you must have tried and not succeeded in losing weight before. Girls must be prepubertal, meaning they have not started puberty yet. You can’t join if you've lost or gained more than 11 pounds in the last 90 days, have obesity due to other health problems, or have certain medical conditions like pancreatitis or diabetes. During the study, blood tests will be done to see how your body handles the medicine.
- Study lasts about 13 weeks.
- Blood tests will be performed.
- Specific health conditions may exclude participation.
Study details
NCT05696847
Eli Lilly and Company
10 July 2024
Not finding the right Trial?
,
You have contacted , on
Your message has been sent to the study team at ,
What happens next?
- You can expect the study team to contact you via email or phone in the next few days.
- Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.
You are contacting
Primary Contact
FAQs
Learn more about clinical trials
What is a clinical trial?
Why should I take part in a clinical trial?
How long does a clinical trial take place?
Do I get compensated for taking part in clinical trials?
How safe are clinical trials?
Study Definition
WikipediaAdd a private note
- Select a piece of text.
- Add notes visible only to you.
- Send it to people through a passcode protected link.